{"type":"rich","version":"1.0","provider_name":"Transistor","provider_url":"https://transistor.fm","author_name":"Ta de Clinicagem","title":"TdC 87 - Insuficiência Cardíaca: Tratamento Ambulatorial","html":"<iframe width=\"100%\" height=\"180\" frameborder=\"no\" scrolling=\"no\" seamless src=\"https://share.transistor.fm/e/08ac5d44\"></iframe>","width":"100%","height":180,"duration":3410,"description":"Joanne, Guilherme e João se reúnem com o dr. José Carlos Lucena para falar de Insuficiência Cardíaca! Um tema super prevalente e cheio de clinicagens! Dessa vez com um enfoque na terapia farmacológica ambulatorial. Como ajustar a dose de furosemida? Qual a melhor hora para iniciar o beta bloqueador? Qual o papel das gliflozinas? Isso e muito mais!\r\n\r\nMinutagem:\r\n(0:35) Apresentação do Convidado Dr. José Carlos Lucena\r\n(3:45) Diuréticos de alça\r\n(18:00) IECA/BRA\r\n(27:00) Betabloqueador\r\n(36:00) Espironolactona\r\n(40:33) Sacubitril Valsartana\r\n(45:00) Gliflozinas\r\n(51:40) Resumo das drogas\r\n(53:36) Desafio da semana\r\n(53:55) Resposta da semana anterior\r\n(55:30) Salves\r\n\r\nReferências:\r\n\r\n Vargo, Dennis L., et al. \"Bioavailability, pharmacokinetics, and pharmacodynamics of torsemide and furosemide in patients with congestive heart failure.\" Clinical Pharmacology & Therapeutics 57.6 (1995): 601-609.\r\n Rohde, Luis E., et al. \"Short-term diuretic withdrawal in stable outpatients with mild heart failure and no fluid retention receiving optimal therapy: a double-blind, multicentre, randomized trial.\" European heart journal 40.44 (2019): 3605-3612.\r\n  Testani, Jeffrey M., et al. \"Potential Effects of Aggressive Decongestion during the Treatment of Decompensated Heart Failure on Renal Function and Survival: Insights from the ESCAPE Trial Limited Dataset.\" Journal of Cardiac Failure 16.8 (2010): S104.\r\n  Chaudhry, Sarwat I., et al. \"Patterns of weight change preceding hospitalization for heart failure.\" Circulation 116.14 (2007): 1549.\r\n  Gattis, Wendy A., et al. \"Predischarge initiation of carvedilol in patients hospitalized for decompensated heart failure: results of the Initiation Management Predischarge: Process for Assessment of Carvedilol Therapy in Heart Failure (IMPACT-HF) trial.\" Journal of the American College of Cardiology 43.9 (2004): 1534-1541.\r\n  Packer, Milton, et al. \"The effect of carvedilol on morbidity and mortality in patients with chronic heart failure.\"...","thumbnail_url":"https://img.transistorcdn.com/lqcQlEC1m6aWV5CJqKTqNKKWbLXziZKK97FisF4ZuuE/rs:fill:0:0:1/w:400/h:400/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS9lODM1/ZmI0ODIxZjAxM2U1/ZGUwMjhkYTYwNzZi/MGNmNi5qcGc.webp","thumbnail_width":300,"thumbnail_height":300}